No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
687 |
4. Check minimum number of eventsNone |
687 |
5. Include endpointsNone |
687 |
6. Filter based on genotype QC (FinnGen only) |
601 |
Control definitions (FinnGen only)
- Control exclude
- AB1_OTHER_BACTERIAL
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF5
Similar endpoints
↥List of similar endpoints to
Infection due to other mycobacteria
based on the number of shared cases.
Similar with more cases:
- Infection due to other mycobacteria, including avohilmo
- Other bacterial diseases
- Other bacterial diseases, including avohilmo
- Certain infectious and parasitic diseases
- Certain infectious and parasitic diseases, including avohilmo
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 4384 | 2364 | 1935 |
| Only index persons | 2970 | 1735 | 1235 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.06 | 0.07 | 0.05 |
| Only index persons | 0.06 | 0.06 | 0.05 |
| Median age at first event (years) | |||
| Whole population | 67.61 | 68.82 | 66.10 |
| Only index persons | 66.78 | 68.03 | 65.03 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 601 | 323 | 278 |
| Unadjusted period prevalence (%) | 0.12 | 0.11 | 0.13 |
| Median age at first event (years) | 67.27 | 65.88 | 68.89 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 628
- Matched controls
- 6280
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
A31.0
ICD-10 Finland
Pulmonary mycobacterial infection
11125.7
307.7
430
*
J47
ICD-10 Finland
Bronchiectasis
45.9
300.9
186
57
UGC12
NOMESCO Finland
Flexible bronchoscopy
15.5
241.2
264
281
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
18.8
220.3
198
150
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
10.2
176.1
267
426
R03BB04
ATC
tiotropium bromide; inhalant
9.4
156.2
242
391
TGC00
NOMESCO Finland
Bronchial lavation
20.2
146.2
119
72
A49.9
ICD-10 Finland
Bacterial infection, unspecified
30.4
141.6
96
37
A31.9
ICD-10 Finland
Mycobacterial infection, unspecified
+∞
137.7
127
*
J01MA14
ATC
moxifloxacin; systemic
9.2
124.7
180
262
J18.9
ICD-10 Finland
Pneumonia, unspecified
6.5
122.9
373
1149
GD1AD
NOMESCO Finland
Thorax CT examination
9.7
116.1
156
207
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
15.5
107.3
99
75
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
5.6
98.0
278
779
J01MA12
ATC
levofloxacin; systemic
5.8
97.3
251
647
R03AK06
ATC
salmeterol and fluticasone; inhalant
6.0
95.2
225
535
R03DA04
ATC
theophylline; systemic, rectal
8.1
82.4
124
185
R04.2
ICD-10 Finland
Haemoptysis
10.7
80.4
94
102
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
8.5
80.2
115
162
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
5.6
77.6
183
427
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
8.2
75.3
110
158
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
5.8
71.9
156
336
GD1AA
NOMESCO Finland
Thorax X-ray examination
4.7
70.1
457
2278
J45.9
ICD-10 Finland
Asthma, unspecified
4.4
65.2
231
739
R03AC12
ATC
salmeterol; inhalant
7.5
64.5
101
156
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
9.5
62.3
78
92
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
9.0
58.8
77
96
A31.89
ICD-10 Finland
Other mycobacterial infections
+∞
57.2
54
*
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
3.9
56.8
425
2205
J45.1
ICD-10 Finland
Nonallergic asthma
6.0
55.6
109
211
H02AB06
ATC
prednisolone; systemic
3.8
55.3
415
2143
J45.0
ICD-10 Finland
Predominantly allergic asthma
5.8
54.8
114
233
A31.1
ICD-10 Finland
Cutaneous mycobacterial infection
551.5
52.3
51
*
R03AC02
ATC
salbutamol; inhalant
3.8
51.2
449
2512
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
6.4
50.9
92
164
R03DC03
ATC
montelukast; oral
4.0
48.4
173
544
R50.9
ICD-10 Finland
Fever, unspecified
4.2
46.8
148
425
H02AB04
ATC
methylprednisolone; systemic
4.0
46.5
167
525
R03BA05
ATC
fluticasone; inhalant
3.7
46.0
189
651
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
9.1
44.0
56
67
XG410
NOMESCO Finland
Flow-volume spirometry
6.9
40.5
66
105
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
5.4
39.9
85
176
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
3.3
39.6
198
765
R03AK08
ATC
formoterol and beclometasone; inhalant
6.5
39.4
68
115
R03AK03
ATC
[U] fenoterol and ipratropium bromide
5.0
39.0
92
208
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
6.7
37.7
63
103
J96.1
ICD-10 Finland
Chronic respiratory failure
8.1
37.5
52
69
A46
ICD-10 Finland
Erysipelas
5.1
37.4
85
186
R03AC03
ATC
terbutaline; inhalant
3.7
36.6
142
465
J46
ICD-10 Finland
Status asthmaticus
9.4
35.8
44
50
0310A
ICD-9 Finland
Diseases due to other mycobacteria, Pulmonary
+∞
35.8
34
*
J01FA06
ATC
roxithromycin; oral
2.8
35.7
328
1754
R03BB01
ATC
ipratropium bromide; inhalant
5.3
34.9
76
160
WW200
NOMESCO Finland
Immunization
9.7
34.2
41
45
H02AB07
ATC
prednisone; oral
3.4
34.2
148
518
R03BA01
ATC
beclometasone; inhalant
3.5
34.0
144
497
R81
ICPC
Pneumonia
6.3
33.7
59
101
J01FA09
ATC
clarithromycin; systemic
2.8
32.1
249
1206
J45.8
ICD-10 Finland
Mixed asthma
7.2
30.5
47
70
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.1
30.2
159
622
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
12.6
30.1
30
25
R03AL08
ATC
vilanterol, umeclidinium bromide and fluticasone furoate; inhalant
8.6
29.8
39
48
R03BA02
ATC
budesonide; inhalant
3.0
29.3
163
657
JN4AD
NOMESCO Finland
Body CT examination
3.5
28.8
116
385
A41.9
ICD-10 Finland
Sepsis, unspecified
+∞
28.3
27
*
A15.0
ICD-10 Finland
Tuberculosis of lung, confirmed by sputum microscopy with or without culture
81.5
28.0
31
*
TDM10
NOMESCO Finland
Puncture of maxillary antrum
6.2
27.5
49
85
R03AC13
ATC
formoterol; inhalant
4.6
27.5
69
163
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
8.5
25.8
34
42
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.4
25.6
107
362
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
4.2
25.5
73
191
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.8
24.8
82
238
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.2
24.6
112
399
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.3
23.6
286
1652
R03BA08
ATC
ciclesonide; inhalant
3.6
22.9
82
251
R03DC01
ATC
zafirlukast; oral
8.5
22.8
30
37
J01AA02
ATC
doxycycline; systemic
2.9
22.7
528
4032
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
4.2
22.2
62
159
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
4.9
22.1
51
112
R95
ICPC
Chron obstructive pulmonary disease
5.4
21.5
44
87
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.3
20.4
231
1279
J01MA02
ATC
ciprofloxacin; systemic
2.2
20.0
283
1713
SPAT1255
SPAT
Intravenous administration of medicine
4.0
19.8
60
163
UDH02
NOMESCO Finland
Rhinopharyngoscopy
3.6
19.8
69
207
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
3.6
19.6
68
203
R03AK07
ATC
formoterol and budesonide; inhalant
2.5
19.4
151
708
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
4.4
19.2
50
121
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
14.8
18.8
31
22
A07AA02
ATC
nystatin; oral
3.7
18.8
63
184
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
195.6
18.6
19
*
49300
ICD-8 Finland
Asthma, bronchiale
6.5
18.6
31
50
J01FA10
ATC
azithromycin; systemic
2.1
18.4
354
2384
M05BA04
ATC
alendronic acid; oral
2.9
18.4
96
367
R28
ICPC
Limited function/disability (R)
7.7
18.4
26
35
J45
ICD-10 Finland
Asthma
3.0
18.2
86
311
R02
ICPC
Shortness of breath/dyspnoea
2.6
18.0
124
547
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
18.8
17.9
27
15
B44.1
ICD-10 Finland
Other pulmonary aspergillosis
68.7
17.8
20
*
A31.80
ICD-10 Finland
Oral infection caused by Mycobacterium intracellulare
+∞
17.8
17
*
J01GB01
ATC
tobramycin; inhalant, parenteral
185.0
17.6
18
*
A02BC02
ATC
pantoprazole; systemic
2.2
17.3
457
3437
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
5.0
16.6
36
75
L04AX01
ATC
azathioprine; systemic
4.8
16.6
38
83
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
2.2
16.5
198
1106
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
3.8
16.4
52
146
R03AK11
ATC
formoterol and fluticasone; inhalant
5.7
16.3
31
57
J02AC01
ATC
fluconazole; systemic
2.1
16.1
243
1477
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
3.4
15.8
61
195
N02AX02
ATC
tramadol; systemic, rectal
2.0
15.5
296
1950
R01AD08
ATC
fluticasone; nasal
2.1
15.4
182
1007
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.0
15.4
73
264
R05
ICD-10 Finland
Cough
2.2
15.3
160
843
A03
ICPC
Fever
2.5
15.0
110
497
JN4BD
NOMESCO Finland
Extensive body CT
2.8
14.9
83
327
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
4.3
14.9
39
95
J41.1
ICD-10 Finland
Mucopurulent chronic bronchitis
58.1
14.8
17
*
L04AA06
ATC
mycophenolic acid; systemic
13.7
14.8
25
19
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
18.9
14.8
22
12
XF400
NOMESCO Finland
ECG with 12 standard connections
2.3
14.8
128
623
C03CA01
ATC
furosemide; systemic
2.0
14.6
247
1553
A15.1
ICD-10 Finland
Tuberculosis of lung, confirmed by culture only
153.4
14.5
15
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.7
14.4
85
345
R06.0
ICD-10 Finland
Dyspnoea
2.0
14.2
207
1231
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
5.0
14.2
31
65
1240
FHL
Bronchoscopy
6.0
14.1
25
43
TPH04
NOMESCO Finland
Cathetrisation of vein
2.1
14.0
157
848
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
5.7
13.9
26
47
L04AD01
ATC
ciclosporin; systemic
11.3
13.6
25
23
03199
ICD-8 Finland
Other diseases due to Mycobacteria, Other and unspecified
+∞
13.6
13
*
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
+∞
13.6
13
*
127
Kela drug reimbursment
Transplant complication
16.7
13.5
21
13
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
13.2
13.5
23
18
R96
ICPC
Asthma
2.7
13.5
80
326
XQ800
NOMESCO Finland
Prick test
3.2
13.3
54
178
R05
ICPC
Cough
2.0
13.3
177
1017
J01CA04
ATC
amoxicillin; systemic
2.1
13.2
499
4048
Z01.8
ICD-10 Finland
Other specified special examinations
2.1
13.2
157
864
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
5.2
13.0
27
54
TPX10
NOMESCO Finland
Implantation of vascular injection port
5.2
13.0
27
54
XG466
NOMESCO Finland
Sleep oxymetry
4.2
13.0
35
87
B90.9
ICD-10 Finland
Sequelae of respiratory and unspecified tuberculosis
19.5
13.0
19
10
J01FF01
ATC
clindamycin; systemic
2.0
13.0
170
970
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
4.7
12.7
30
67
R03DX07
ATC
roflumilast; oral
71.3
12.6
14
*
J02AC03
ATC
voriconazole; systemic
71.3
12.6
14
*
R01AD09
ATC
mometasone; nasal
1.9
12.6
274
1847
WX892
NOMESCO Finland
Monitored bed care
2.9
12.6
64
240
A41.8
ICD-10 Finland
Other specified sepsis
+∞
12.5
12
*
ZXE00
NOMESCO Finland
One hour or less
1.9
12.5
252
1657
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.1
12.3
145
793
348
Kela drug reimbursment
Roflumilast
30.7
11.7
15
5
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
3.1
11.6
49
165
ZX108
NOMESCO Finland
Inhalation
23.4
11.6
16
7
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
4.1
11.6
32
81
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.8
11.5
270
1848
A16.0
ICD-10 Finland
Tuberculosis of lung, bacteriologically and histologically negative
35.7
11.3
14
*
H02AB09
ATC
hydrocortisone; systemic
5.7
11.2
21
38
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
8.3
11.2
24
30
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
8.3
11.2
24
30
R4190
NOMESCO Finland
Nutritional therapy
3.8
11.1
34
93
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
5.9
11.1
20
35
N02AA05
ATC
oxycodone; systemic
2.0
11.1
142
799
XW000
NOMESCO Finland
Bone marrow biopsy
3.7
10.9
35
99
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
3.5
10.9
37
109
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
3.1
10.8
46
156
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
4.9
10.8
24
51
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
18.2
10.8
16
9
A03FA01
ATC
metoclopramide; systemic, rectal
2.0
10.8
149
860
M05BB03
ATC
alendronic acid and colecalciferol; oral
4.4
10.7
27
64
L04AA01
ATC
[U] ciclosporin
11.5
10.6
19
17
R03BB02
ATC
oxitropium bromide; inhalant
10.3
10.6
20
20
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.2
10.5
42
137
A01AB04
ATC
amphotericin B; local oral
2.9
10.5
50
181
4912B
ICD-9 Finland
Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]
5.6
10.5
20
37
M81.9
ICD-10 Finland
Osteoporosis, unspecified
3.1
10.4
45
154
A01AB09
ATC
miconazole; local oral
2.5
10.4
71
309
J01.0
ICD-10 Finland
Acute maxillary sinusitis
2.0
10.3
143
824
SPAT1017
SPAT
Examination of colour vision
23.8
10.3
14
6
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
2.3
10.1
79
366
TPH07
NOMESCO Finland
Cathetrisation of artery
2.3
10.0
82
387
R11
ICD-10 Finland
Nausea and vomiting
2.5
9.9
68
296
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
12.4
9.9
17
14
S97
ICPC
Chronic ulcer skin
2.9
9.8
48
176
J20
ICD-10 Finland
Acute bronchitis
2.3
9.8
76
350
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.2
9.8
92
459
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.8
9.8
168
1038
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
2.9
9.7
48
177
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
4.0
9.7
27
69
JN3AD
NOMESCO Finland
Abdominal CT examination
2.2
9.6
84
408
B02AA02
ATC
tranexamic acid; systemic
2.2
9.5
87
429
B44.0
ICD-10 Finland
Invasive pulmonary aspergillosis
+∞
9.4
9
*
A02BC05
ATC
esomeprazole; systemic
1.7
9.4
256
1803
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
3.2
9.2
37
121
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.3
9.1
75
354
R05CB01
ATC
acetylcysteine; inhalant, oral
4.7
9.1
21
46
B03XA02
ATC
darbepoetin alfa; parenteral
4.9
9.1
20
42
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
4.2
9.1
24
59
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.3
9.0
73
342
4940A
ICD-9 Finland
Bronchiectasis[BRONCHIECTASIAE]
37.3
9.0
11
*
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
7.0
8.9
21
31
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
7.0
8.9
21
31
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
4.6
8.9
21
47
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
4.1
8.9
24
60
R03BB07
ATC
umeclidinium bromide; inhalant
10.9
8.8
16
15
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
3.8
8.8
27
74
Z2221
NOMESCO Finland
Medical doctor
1.8
8.8
169
1075
R99
ICPC
Respiratory disease other
4.5
8.7
21
48
ZXD05
NOMESCO Finland
Urgent procedure
1.7
8.5
178
1158
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.8
8.5
163
1034
KA1AE
NOMESCO Finland
Kidney ultrasound examination
4.3
8.5
22
53
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
3.3
8.5
31
96
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
2.6
8.4
49
197
B44.8
ICD-10 Finland
Other forms of aspergillosis
91.2
8.4
9
*
ZX120
NOMESCO Finland
Intravenous
2.3
8.4
64
292
TB101, ,
NOMESCO Finland
+∞
8.3
8
*
E84.0
ICD-10 Finland
Cystic fibrosis with pulmonary manifestations
+∞
8.3
8
*
B05XA03
ATC
sodium chloride; parenteral
+∞
8.3
8
*
R06AE07
ATC
cetirizine; oral
1.7
8.3
243
1729
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
3.9
8.3
24
63
Z2446
NOMESCO Finland
Social worker
2.6
8.3
47
187
A02BA02
ATC
ranitidine; systemic
1.8
8.1
143
884
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.7
8.1
43
165
P01BA02
ATC
hydroxychloroquine; oral
2.4
8.1
59
264
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
33.8
8.1
10
*
A07AA09
ATC
vancomycin; oral
9.1
8.1
16
18
J15.8
ICD-10 Finland
Other bacterial pneumonia
10.2
8.1
15
15
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
3.1
8.0
34
115
J01DB01
ATC
cefalexin; oral
1.7
8.0
478
4057
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.3
7.9
61
280
R03AL04
ATC
indacaterol and glycopyrronium bromide; inhalant
13.2
7.9
13
10
M05BX04
ATC
denosumab; parenteral
2.5
7.9
52
223
N02AA01
ATC
morphine; systemic, rectal
3.7
7.8
24
66
4730A
ICD-9 Finland
Chronic sinusitis, Maxillary
4.4
7.7
19
44
A04AA01
ATC
ondansetron; systemic, rectal
2.4
7.7
55
244
4859X
ICD-9 Finland
Bronchopneumonia, organism unspecified[PNEUMONIA NUD]
3.6
7.6
25
72
J01DA06
ATC
[U] cefuroxime
2.0
7.6
91
496
J15.1
ICD-10 Finland
Pneumonia due to Pseudomonas
25.3
7.6
10
*
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.9
7.5
106
610
J01FA15
ATC
telithromycin; oral
2.3
7.5
61
286
J01DA01
ATC
[U] cefalexin
1.6
7.5
371
2977
SPAT1149
SPAT
Suture or treatment of traumatic wound
2.1
7.5
79
411
N17.9
ICD-10 Finland
Acute renal failure, unspecified
3.3
7.5
28
88
0110A
ICD-9 Finland
Pulmonary tuberculosis, Tuberculosis of lung, infiltrative[TUBERCULOSIS PULMONUM INFILTRATIVA, BAKTER.VARMA]
81.0
7.4
8
*
J01XB01
ATC
colistin; inhalant, parenteral
81.0
7.4
8
*
A15.2
ICD-10 Finland
Tuberculosis of lung, confirmed histologically
81.0
7.4
8
*
J01XX08
ATC
linezolid; systemic
13.6
7.4
12
9
Z3231
NOMESCO Finland
Registered nurse
1.7
7.4
167
1105
R29
ICPC
Respiratory symptom/complaint other
2.4
7.4
50
217
R78
ICPC
Acute bronchitis/bronchiolitis
3.9
7.3
21
55
B96.5
ICD-10 Finland
Pseudomonas (aeruginosa) as the cause of diseases classified to other chapters
+∞
7.3
7
*
XCW12, ,
SPAT
+∞
7.3
7
*
304
Kela drug reimbursment
Dornase alfa
+∞
7.3
7
*
R05CB13
ATC
dornase alfa (desoxyribonuclease); inhalant
+∞
7.3
7
*
-60
ICPC
Result test/procedure
2.6
7.2
43
175
A11CC03
ATC
alfacalcidol; systemic
4.6
7.2
17
38
WZC30
NOMESCO Finland
Teaching
1.9
7.2
103
596
WX408
NOMESCO Finland
General anesthesy, balanced
1.7
7.2
151
979
R03AL03
ATC
vilanterol and umeclidinium bromide; inhalant
8.1
7.1
15
19
NF1AA
NOMESCO Finland
Hip X-ray examination
2.1
7.1
70
355
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.8
7.1
107
629
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.4
7.0
46
197
WW500
NOMESCO Finland
Blood transfusion
3.1
7.0
28
92
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
3.6
6.9
22
62
Z03.0
ICD-10 Finland
Observation for suspected tuberculosis
14.0
6.9
11
8
N03AX16
ATC
[U] pregabalin
1.7
6.9
140
899
UJF30
NOMESCO Finland
Ileoscopy through colon
2.1
6.9
71
367
XF600
NOMESCO Finland
Bloodpressure measurement
2.4
6.8
46
199
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
9.5
6.8
13
14
4930A
ICD-9 Finland
Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]
9.5
6.8
13
14
J32.4
ICD-10 Finland
Chronic pansinusitis
6.2
6.8
17
28
Z94.2
ICD-10 Finland
Lung transplant status
40.5
6.8
8
*
ZZA00
NOMESCO Finland
Split skin graft
3.6
6.8
22
63
L04AD02
ATC
tacrolimus; systemic
16.9
6.8
10
6
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
16.9
6.8
10
6
J43.9
ICD-10 Finland
Emphysema, unspecified
4.0
6.8
19
49
R24
ICPC
Haemoptysis
6.5
6.7
16
25
Z94.0
ICD-10 Finland
Kidney transplant status
12.4
6.6
11
9
R01AD58
ATC
fluticasone, combinations; nasal
1.7
6.6
121
755
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.1
6.5
63
317
C07AB07
ATC
bisoprolol; oral
1.5
6.5
322
2552
G04BD11
ATC
fesoterodine; oral
3.4
6.5
23
70
J33.0
ICD-10 Finland
Polyp of nasal cavity
3.4
6.5
23
70
UKC02
NOMESCO Finland
Cystoscopy
1.8
6.4
110
671
XCK00
NOMESCO Finland
Perimetry
2.3
6.4
47
211
J01CE08
ATC
benzathine benzylpenicillin; parenteral
70.5
6.4
7
*
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
2.7
6.4
33
125
A01AB10
ATC
natamycin; local oral
3.1
6.4
26
86
UGC18
NOMESCO Finland
Flexible bronchoscopy with biopsy of lung
14.5
6.4
10
7
J31.0
ICD-10 Finland
Chronic rhinitis
2.2
6.4
53
251
Z3226
NOMESCO Finland
Physiotherapist
1.8
6.4
115
712
J40
ICD-10 Finland
Bronchitis, not specified as acute or chronic
3.2
6.4
25
81
M05BA06
ATC
ibandronic acid; systemic
3.5
6.3
21
61
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
3.4
6.3
22
66
J04AB02
ATC
rifampicin; systemic
9.4
6.3
12
13
N05CF01
ATC
zopiclone; oral
1.6
6.3
210
1522
WZC00
NOMESCO Finland
Treatment plan or consultation
1.6
6.3
206
1487
A31.8
ICD-10 Finland
Other mycobacterial infections
+∞
6.3
6
*
9961/3-C42.1
ICD-O-3
Primary myelofibrosis of bone marrow
+∞
6.3
6
*
E84.9
ICD-10 Finland
Cystic fibrosis, unspecified
+∞
6.3
6
*
J02AC04
ATC
posaconazole; systemic
+∞
6.3
6
*
J44
ICD-10 Finland
Other chronic obstructive pulmonary disease
3.6
6.2
20
57
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.4
6.2
43
189
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.1
6.2
59
296
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
6.1
208
1511
R03AL11
ATC
formoterol, glycopyrronium bromide and budesonide; inhalant
7.8
6.1
13
17
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
3.2
6.1
24
78
B23.1
ICD-10 Finland
HIV disease resulting in (persistent) generalized lymphadenopathy
12.7
6.1
10
8
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
8.7
6.1
12
14
R03CC02
ATC
salbutamol; systemic
3.0
6.1
26
89
Z49.1
ICD-10 Finland
Extracorporeal dialysis
10.2
6.0
11
11
J01CF02
ATC
cloxacillin; systemic
5.3
6.0
17
33
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
272
172
27.13
307.65
9.1
2.7
—
—
—
0
0
130
56
29.01
185.59
13.8
3.6
—
—
—
0
0
88
19
53.70
152.39
14.4
2.8
—
—
—
0
0
140
111
15.94
149.41
2.8
1.3
—
—
—
0
0
120
97
15.06
125.92
1.9
1.3
—
—
—
0
0
112
83
16.21
123.40
1.9
1.3
—
—
—
0
0
83
34
27.98
119.44
1.9
1.2
2.14
1.12
u/ml
0.35
63
20
91
62
17.00
104.46
1.8
1.3
—
—
—
0
0
92
67
15.92
101.84
1.3
1.1
—
—
—
0
0
186
348
7.17
101.45
3.1
2.4
10.40
10.93
g/l
0.65
178
310
73
34
24.16
99.71
1.9
1.4
—
—
—
0
0
96
79
14.16
99.01
1.8
1.4
—
—
—
0
0
149
269
6.95
83.08
1.8
1.7
1.35
1.64
g/l
0.46
138
242
96
108
10.31
79.97
2.3
1.3
—
—
—
0
0
97
113
9.97
78.70
2.4
1.3
—
—
—
0
0
77
69
12.58
74.86
2.4
1.4
—
—
—
0
0
146
294
6.17
72.34
2.1
1.2
142.61
289.43
u/ml
0.86
139
276
48
22
23.54
65.50
2.8
1.8
1.73
0.48
e9/l
0.67
48
22
43
20
23.01
58.22
1.9
1.2
—
—
—
0
0
42
19
23.62
57.48
1.6
1.0
—
—
—
0
0
41
18
24.30
56.76
1.9
1.2
—
—
—
0
0
41
18
24.30
56.76
3.1
2.4
—
—
—
0
0
240
864
3.88
56.14
3.2
1.7
—
—
—
0
0
59
55
11.74
55.60
12.1
4.8
201.15
100.00
iu/ml
—
13
5
41
19
23.02
55.55
1.9
1.2
—
—
—
0
0
59
56
11.52
54.93
2.4
1.3
—
—
—
0
0
55
53
11.28
50.62
2.2
1.2
—
—
—
0
0
218
832
3.48
45.21
7.6
2.8
0.81
0.82
mmol/l
0.75
209
785
121
320
4.45
42.39
2.0
1.5
—
—
—
0
0
64
95
7.39
41.92
1.9
1.4
—
—
—
0
0
461
2860
3.30
39.55
21.6
7.7
4.68
4.04
e9/l
5.94
440
2466
39
33
12.53
38.88
1.9
1.2
—
—
—
0
0
59
93
6.90
36.49
1.3
1.2
192.00
133.33
titre
—
5
6
104
276
4.32
35.99
5.8
3.0
1.93
2.13
mmol/l
0.17
82
207
69
136
5.58
34.03
1.9
1.5
0.29
0.16
iu/ml
0.26
14
20
169
662
3.12
32.23
2.9
1.7
—
—
—
0
0
35
36
10.24
30.58
1.9
1.4
—
—
—
0
0
35
36
10.24
30.58
1.9
1.4
—
—
—
0
0
35
36
10.24
30.58
1.9
1.4
—
—
—
0
0
36
41
9.25
29.19
2.6
1.6
—
—
—
0
0
158
627
3.03
29.17
2.8
1.7
—
—
—
0
0
209
964
2.75
29.15
1.8
1.4
2.61
2.49
g/l
0.36
152
523
421
2768
2.58
27.24
15.9
5.2
9.24
11.23
umol/l
9.41
414
2620
36
45
8.43
27.13
2.6
1.5
—
—
—
0
0
71
188
4.13
24.35
3.7
1.6
—
—
—
0
0
65
172
4.10
22.28
3.1
1.6
—
—
—
0
0
410
2802
2.33
22.20
14.2
5.8
1.21
1.22
mmol/l
0.94
349
2395
376
2520
2.23
20.76
12.6
5.4
1.22
1.22
mmol/l
0.09
359
2288
31
48
6.74
19.36
1.1
1.0
—
—
—
0
0
132
590
2.57
18.69
7.1
3.7
243.36
241.21
u/l
0.06
126
552
242
1414
2.16
18.32
2.9
2.2
3.04
2.93
mg/l
0.25
215
1185
48
120
4.25
17.69
2.4
1.9
123.06
130.55
g/l
1.08
36
92
356
2442
2.06
17.18
7.9
4.1
33.32
35.94
g/l
12.15
336
2268
41
93
4.65
17.07
1.7
1.2
—
—
—
0
0
41
93
4.65
17.07
1.7
1.2
—
—
—
0
0
152
753
2.34
17.05
3.9
2.2
17.93
22.54
%
5.48
140
690
168
873
2.26
16.81
3.7
2.2
10.51
12.89
umol/l
4.83
155
795
27
18
15.61
16.80
2.0
1.2
—
—
—
0
0
27
18
15.61
16.80
2.0
1.2
—
—
—
0
0
27
18
15.61
16.80
2.0
1.2
—
—
—
0
0
27
18
15.61
16.80
2.0
1.2
—
—
—
0
0
107
462
2.59
16.12
1.8
2.5
64.44
66.52
g/l
1.60
95
417
100
418
2.66
16.09
2.1
1.4
—
—
—
0
0
156
806
2.24
15.71
3.9
2.2
2.20
2.31
g/l
1.56
142
731
489
3850
2.22
15.42
12.7
4.2
18.46
12.24
mm/h
12.31
480
3533
39
93
4.41
15.26
2.6
1.5
—
—
—
0
0
21
11
19.70
14.31
2.1
1.4
—
—
—
0
0
21
11
19.70
14.31
2.2
1.4
—
—
—
0
0
21
11
19.70
14.31
2.1
1.4
—
—
—
0
0
24
40
6.20
13.95
1.5
1.2
51.42
43.73
u/l
0.52
24
32
79
315
2.72
13.88
2.4
1.6
—
—
—
0
0
132
669
2.23
13.77
13.0
3.8
1.06
1.03
mmol/l
0.77
123
595
327
2292
1.89
13.62
4.1
2.8
130.86
115.69
ug/l
0.60
307
2087
25
26
9.97
12.83
4.3
2.8
37.22
38.98
%
0.09
12
16
17
7
24.89
12.52
3.0
1.7
1.74
1.66
ratio
—
17
7
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
46
143
3.39
12.43
4.1
2.7
0.40
0.40
iu/ml
0.04
27
86
119
608
2.18
12.05
10.1
7.1
1.86
0.96
mmol/l
1.23
104
504
29
66
4.56
12.02
1.4
1.2
165.71
143.52
au/ml
—
7
20
100
480
2.29
11.77
2.3
1.9
302.69
385.28
nmol/l
3.38
94
443
350
2581
1.80
11.69
22.8
14.4
1.29
1.27
inr
0.17
306
2131
50
172
3.07
11.46
1.6
3.2
12.42
2.70
ratio
0.43
27
98
20
17
12.11
11.40
2.3
2.5
552.55
687.53
u/ml
0.41
20
17
52
188
2.93
10.93
1.8
3.5
140.57
75.02
mg/l
0.34
43
163
351
2624
1.77
10.88
3.5
2.6
—
—
—
0
0
52
189
2.91
10.83
1.7
3.5
38.16
54.46
mg/l
0.49
43
166
14
5
28.58
10.76
1.1
1.0
95.86
100.20
%
—
14
5
89
426
2.27
10.51
18.2
4.8
9.75
9.56
mmol/l
0.10
84
403
90
434
2.25
10.44
7.6
3.1
1.23
1.23
mmol/l
0.09
83
369
314
2292
1.74
10.43
30.1
10.0
0.00
0.00
e9/l
0.02
276
1894
264
1836
1.76
10.40
4.5
3.1
1448.65
1293.58
ng/l
0.24
245
1575
36
108
3.48
10.28
1.3
1.0
—
5.79
—
0
10
37
114
3.39
10.15
1.5
1.2
—
—
—
0
0
27
68
4.10
9.86
1.5
1.3
—
—
—
0
0
18
17
10.86
9.83
4.7
1.6
1.87
1.98
umol/l
0.20
18
12
44
157
2.94
9.48
1.5
1.1
—
—
—
0
0
170
1069
1.81
9.26
3.0
1.6
1.64
1.34
mg/l
0.26
139
836
273
1967
1.69
9.13
5.4
3.1
2.35
2.36
mmol/l
1.34
254
1760
37
123
3.13
9.00
4.6
2.0
96.27
92.39
%
0.38
37
117
50
197
2.67
8.96
1.9
2.5
1.18
0.82
g/l
0.20
45
169
150
916
1.84
8.95
1.3
1.3
66.93
36.11
iu/ml
0.63
53
284
22
51
4.43
8.93
1.1
1.1
1.51
1.54
g/l
0.14
22
43
476
3991
1.80
8.91
22.4
6.8
81.92
78.70
u/l
0.77
471
3735
26
69
3.89
8.87
1.3
1.2
—
—
—
0
0
391
3115
1.68
8.73
9.8
4.5
6.42
6.63
mmol/l
1.64
382
2947
99
531
2.03
8.69
8.2
2.6
2.58
1.90
mmol/l
0.96
91
452
12
6
20.35
8.49
2.9
1.2
—
—
—
0
0
54
233
2.44
8.05
1.5
1.3
—
—
—
0
0
234
1662
1.65
8.01
3.4
2.2
58.52
113.77
u/l
0.59
223
1525
48
197
2.56
7.94
2.0
2.2
9.91
10.43
g/l
0.37
43
169
52
225
2.43
7.70
2.2
1.7
1.61
1.51
g/l
0.35
45
197
39
147
2.76
7.63
1.5
1.2
—
—
—
0
0
18
42
4.38
7.26
4.8
2.3
—
—
—
0
0
245
1799
1.59
7.13
6.6
3.2
31.44
95.62
e6/l
0.93
211
1388
29
96
3.12
7.13
4.8
2.5
9.51
7.08
pmol/l
0.73
29
96
237
1727
1.60
7.12
1.8
1.7
19.51
20.97
nmol/l
0.86
202
1417
219
1568
1.61
7.07
6.6
3.0
0.19
0.40
e6/l
2.41
187
1159
19
48
4.05
6.93
2.2
1.4
55.07
62.19
%
0.28
14
31
23
68
3.47
6.75
1.3
1.2
383.81
267.86
u/ml
0.54
17
29
92
524
1.89
6.73
5.8
3.1
—
—
—
0
0
22
65
3.47
6.47
1.7
1.3
—
—
—
0
0
22
66
3.42
6.33
1.7
1.3
—
—
—
0
0
22
66
3.42
6.33
1.7
1.3
—
—
—
0
0
32
121
2.73
6.25
4.2
3.1
1.89
1.43
index
0.14
18
61
222
1638
1.55
6.12
5.3
2.8
30.53
33.94
u/l
0.68
215
1535
95
563
1.81
6.12
2.6
2.2
6.15
6.71
umol/l
0.21
86
498
14
22
6.48
5.88
1.7
1.2
45.93
15.31
u/l
0.76
14
16
21
65
3.31
5.77
1.8
1.3
—
—
—
0
0
21
65
3.31
5.77
1.8
1.3
—
—
—
0
0
100
612
1.75
5.77
2.3
2.2
165.77
122.20
ug/g
0.82
70
477
271
2108
1.50
5.75
6.4
3.8
72.70
82.21
ng/l
0.08
213
1587
21
66
3.26
5.64
1.8
1.3
—
—
—
0
0
14
24
5.94
5.55
15.4
7.3
50.25
60.50
u/ml
—
8
6
77
446
1.83
5.33
3.7
3.0
142.15
197.55
ng/l
1.41
71
405
13
22
6.01
5.24
1.8
1.2
138.00
74.29
u/l
1.06
13
17
300
2413
1.47
5.23
3.4
2.3
82.39
79.24
nmol/l
1.22
279
2115
42
201
2.17
4.98
2.3
1.9
10.91
9.29
iu/ml
0.13
14
56
11
16
6.97
4.97
1.6
1.3
—
—
—
0
0
11
16
6.97
4.97
1.6
1.3
—
—
—
0
0
74
434
1.80
4.93
5.1
2.7
75.62
76.77
ng/l
0.05
69
378
35
156
2.32
4.91
1.4
1.3
256.71
308.85
ug/g
0.63
21
86
144
1007
1.56
4.90
1.9
1.8
1348.11
1173.27
nmol/l
1.37
108
738
15
42
3.63
4.79
1.6
1.1
—
—
—
0
0
36
165
2.25
4.75
1.8
1.6
—
—
—
0
0
111
738
1.61
4.66
15.7
6.0
103.31
104.26
mmol/l
1.12
111
738
327
2730
1.41
4.37
6.2
4.1
0.00
0.00
estimate
-0.00
97
573
9
12
7.59
4.36
1.2
1.1
—
—
—
0
0
18
61
3.01
4.31
3.8
2.2
34.75
21.97
mg/l
—
8
24
11
20
5.58
4.30
1.6
1.4
—
—
—
0
0
13
29
4.55
4.26
2.8
1.2
10.93
22.43
umol/l
1.30
13
24
78
488
1.68
4.15
2.6
2.1
33.03
34.38
u/l
0.14
68
411
331
2787
1.40
4.12
6.1
4.1
0.00
0.55
estimate
0.52
97
562
327
2756
1.39
4.00
6.1
4.1
0.05
2.78
estimate
0.49
98
585
169
1270
1.45
3.99
3.7
2.3
—
—
—
0
0
121
852
1.52
3.94
1.3
1.3
17.16
12.98
u/ml
0.18
36
323
17
59
2.93
3.92
1.5
1.2
1.43
1.47
u/ml
—
7
19
31
146
2.18
3.87
1.3
1.3
2.36
5.90
u/ml
—
5
32
31
146
2.18
3.87
1.3
1.3
1.78
2.69
u/ml
—
5
21
13
33
4.00
3.81
1.0
1.1
—
—
—
0
0
7
8
8.83
3.78
1.1
1.0
—
—
—
0
0
167
1266
1.43
3.73
5.2
2.5
342.23
346.88
umol/l
0.23
155
1076
17
61
2.84
3.71
1.1
1.0
—
1.07
—
0
6
459
4994
0.70
3.70
6.3
6.2
2.55
2.64
mmol/l
1.50
420
4554
10
20
5.06
3.70
1.7
1.4
—
—
—
0
0
8
12
6.74
3.68
1.3
1.4
—
—
—
0
0
18
69
2.66
3.50
1.3
1.3
1772.54
1531.57
e6/l
0.17
13
47
447
4868
0.72
3.41
5.6
5.2
1.58
1.49
mmol/l
3.37
406
4426
214
1717
1.37
3.40
3.4
2.1
123.63
201.68
u/l
2.31
205
1606
199
1581
1.38
3.35
6.3
4.2
0.00
0.00
estimate
0.50
88
532
131
971
1.44
3.28
5.5
2.8
0.60
1.05
e6/l
2.28
84
534
13
39
3.38
3.24
1.3
1.2
—
—
—
0
0
13
39
3.38
3.24
1.3
1.2
—
—
—
0
0
451
4893
0.72
3.22
5.7
5.3
4.53
4.58
mmol/l
0.44
408
4477
25
117
2.18
3.20
2.2
1.5
—
—
—
0
0
13
40
3.30
3.15
1.5
1.2
83.15
103.40
%
1.77
13
35
64
410
1.62
3.14
3.8
2.5
71.85
63.06
ml/min/173m2
1.01
34
172
13
45
2.93
3.04
1.7
1.2
—
—
—
0
0
158
1227
1.38
3.02
3.5
2.8
2.49
2.46
mmol/l
2.04
144
1107
5
5
10.07
2.98
1.2
1.2
—
—
—
0
0
10
27
3.75
2.89
1.1
1.1
19.10
21.76
u/l
—
10
22
12
38
3.20
2.86
1.4
1.3
—
—
—
0
0
356
3969
0.76
2.82
48.0
20.0
328.25
331.76
g/l
9.44
356
3943
295
2536
1.31
2.80
2.3
2.2
94.52
96.62
pmol/l
0.37
180
1266
25
127
2.01
2.64
2.1
1.3
—
—
—
0
0
15
61
2.49
2.63
1.3
1.3
37115.56
25677.50
e6/l
—
9
32
22
107
2.09
2.60
2.4
2.4
162.48
93.29
ug/min
0.46
13
56
452
4860
0.75
2.60
6.0
5.5
5.83
5.97
mmol/l
1.51
418
4370
12
44
2.76
2.56
1.3
1.1
105.50
108.41
pmol/l
0.08
12
44
10
31
3.26
2.52
1.3
1.0
—
—
—
0
0
145
1142
1.35
2.51
1.3
1.3
1.06
1.28
u/ml
0.29
26
281
354
3147
1.29
2.50
6.7
3.0
51.20
47.88
u/l
0.33
339
2912
14
57
2.49
2.46
1.4
1.1
—
—
—
0
0
116
887
1.38
2.41
6.4
3.0
1.88
2.40
e6/l
0.28
69
451
10
33
3.06
2.36
1.5
2.6
—
—
—
0
0
9
28
3.25
2.31
2.1
1.3
—
—
—
0
0
16
72
2.25
2.29
3.9
1.5
31.69
32.21
pg
0.22
16
72
148
1186
1.32
2.27
1.8
1.7
481.33
18515097.27
pmol/l
0.75
120
956
50
329
1.56
2.25
6.6
6.2
25.99
24.69
mmol/l
0.92
50
311
5
9
5.59
2.21
1.2
1.0
—
—
—
0
0
137
1091
1.33
2.19
5.4
3.9
578.18
302.05
ng/l
0.62
117
893
11
42
2.65
2.15
2.8
3.0
420.18
754.88
mg
0.88
11
42
45
295
1.57
2.07
20.2
8.5
15.41
15.99
%
0.89
45
279
7
20
3.53
2.06
1.6
1.2
—
—
—
0
0
446
4761
0.78
2.04
6.8
6.7
39.02
39.37
mmol/mol
0.42
418
4401
6
15
4.03
2.04
1.0
1.1
—
—
—
0
0
7
21
3.36
1.97
4.4
2.9
0.86
0.86
index
—
7
21
66
476
1.43
1.94
3.1
2.5
8.69
7.64
ug/l
0.21
54
410
7
22
3.21
1.88
1.1
1.9
42.70
40.16
g/l
—
7
22
33
206
1.64
1.87
1.8
1.3
—
—
—
0
0
6
17
3.55
1.84
1.0
1.2
—
—
—
0
0
22
124
1.80
1.78
1.8
1.2
—
—
—
0
0
436
4633
0.81
1.67
4.7
4.4
1.14
1.25
mmol/l
3.88
390
4165
24
143
1.71
1.63
1.4
1.2
—
—
—
0
0
271
2421
1.21
1.57
4.1
2.6
—
—
estimate
—
0
0
10
44
2.29
1.56
1.5
1.6
—
—
—
0
0
516
4919
1.27
1.54
47.3
14.0
22.87
23.21
mg/l
0.10
493
3996
8
33
2.44
1.54
1.5
1.5
64.25
81.76
umol/l
—
8
33
6
21
2.87
1.51
1.5
1.0
1713.17
1454.00
miu/ml
—
6
21
9
38
2.39
1.46
1.1
1.2
—
—
—
0
0
7
28
2.52
1.45
1.1
1.1
—
14.22
—
0
13
36
246
1.49
1.43
3.9
2.7
26.53
25.48
mmol/l
0.73
36
237
9
39
2.33
1.43
1.0
1.2
—
—
—
0
0
9
40
2.27
1.40
1.1
1.2
—
—
—
0
0
9
40
2.27
1.40
1.1
1.2
—
—
—
0
0
50
669
0.73
1.38
12.9
6.7
—
—
—
0
0
6
23
2.62
1.37
2.7
2.6
—
—
—
0
0
10
47
2.15
1.34
1.1
1.2
—
—
—
0
0
23
145
1.61
1.30
1.4
1.2
—
—
—
0
0
8
35
2.30
1.27
1.3
1.0
—
—
—
0
0
114
1351
0.81
1.25
4.5
4.9
20.97
21.61
%
0.17
54
695
6
25
2.41
1.24
1.8
1.1
—
—
—
0
0
9
45
2.01
1.23
1.1
1.2
—
—
—
0
0
417
3929
1.18
1.20
5.0
4.3
15.15
14.94
pmol/l
0.92
387
3551
21
135
1.57
1.12
1.5
1.2
—
—
—
0
0
5
23
2.18
0.98
2.6
1.1
—
—
—
0
0
9
50
1.81
0.97
1.2
1.0
—
—
—
0
0
517
5325
0.84
0.94
61.3
22.8
4.32
4.46
e12/l
9.13
512
5191
6
27
2.23
0.93
1.0
1.1
—
—
—
0
0
6
27
2.23
0.93
1.7
1.4
—
—
—
0
0
6
27
2.23
0.93
1.7
1.4
—
—
—
0
0
165
1473
1.16
0.90
6.0
3.4
2.87
0.06
estimate
0.48
87
468
108
1243
0.84
0.88
5.8
4.3
1.02
1.02
kg/l
1.84
68
821
83
699
1.22
0.88
1.5
1.5
—
—
—
0
0
0
26
0.00
0.78
0.0
2.2
—
48.73
—
0
20
19
132
1.45
0.76
1.1
1.4
—
—
—
0
0
9
53
1.71
0.75
1.2
1.0
—
—
—
0
0
9
57
1.59
0.71
2.0
1.4
—
—
—
0
0
5
26
1.93
0.70
1.2
1.1
324.80
261.79
mg/l
—
5
19
7
41
1.72
0.70
1.0
1.0
—
—
—
0
0
40
321
1.26
0.68
2.9
2.7
32.16
20.30
au/ml
—
5
26
225
2095
1.12
0.64
6.2
4.0
0.00
0.02
estimate
1.48
83
475
5
29
1.73
0.64
5.2
4.6
1038.40
200.93
nmol/l
—
5
29
16
114
1.41
0.59
22.3
1.6
65.75
57.26
%
0.96
16
114
8
54
1.49
0.57
8.3
2.8
33.66
72.39
u/ml
—
8
54
204
2183
0.90
0.57
2.2
1.9
1.22
1.31
mmol/l
1.07
169
1798
8
55
1.46
0.56
1.3
1.1
—
—
—
0
0
9
62
1.46
0.53
1.4
2.1
4.57
5.61
u/ml
—
9
62
89
995
0.88
0.53
3.6
3.4
0.80
0.80
ug/l
0.00
66
666
156
1681
0.90
0.49
6.0
6.0
2.65
2.74
ug/l
0.06
140
1491
7
108
0.64
0.49
1.4
1.4
—
—
—
0
0
14
103
1.37
0.45
1.1
1.5
233.80
277.40
miu/ml
—
5
41
10
69
1.46
0.44
1.3
1.5
—
—
—
0
0
5
33
1.52
0.41
1.2
1.6
58.37
56.66
ug/l
—
5
33
9
68
1.33
0.37
1.0
1.0
—
—
—
0
0
76
691
1.11
0.35
4.7
5.1
35.84
32.48
%
1.70
57
413
9
126
0.71
0.35
1.0
1.2
1.02
0.93
g/l
—
9
126
21
173
1.22
0.33
1.1
1.4
0.35
0.32
mg/l
—
8
73
33
377
0.87
0.30
1.7
2.1
2.91
3.40
ratio
1.53
25
312
11
141
0.78
0.29
1.7
1.9
48.45
41.09
nmol/l
0.57
11
134
181
1892
0.94
0.28
5.0
3.9
15.35
7.55
mg/mmol
1.10
118
1158
9
119
0.75
0.27
1.0
1.2
1.64
1.56
g/l
—
9
119
184
1920
0.94
0.27
4.2
3.2
5.98
7.33
mmol/l
5.22
163
1599
25
289
0.86
0.27
6.0
3.3
1.02
1.02
ratio
0.08
20
274
5
40
1.25
0.22
1.0
1.8
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
0.86
—
0
5
0
10
0.00
0.21
0.0
1.0
—
32.82
—
0
10
0
10
0.00
0.21
0.0
1.7
—
7.35
—
0
10
23
261
0.88
0.20
1.8
2.0
3.17
3.49
mmol/l
0.71
17
200
9
112
0.80
0.20
1.4
1.9
155.89
217.04
pmol/l
—
9
104
6
51
1.18
0.19
6.5
3.7
5.50
7.98
nmol/l
—
6
51
11
132
0.83
0.18
1.6
1.8
—
—
—
0
0
30
331
0.90
0.18
2.7
2.1
—
—
—
0
0
36
392
0.91
0.17
2.3
2.3
10.57
13.52
nmol/l
1.50
29
347
11
130
0.84
0.16
2.3
1.7
3.07
53.15
iu/l
—
6
49
484
4800
1.04
0.12
36.5
15.0
77.26
76.19
ml/min/173m2
0.52
467
4470
27
249
1.09
0.12
1.0
1.1
—
—
—
0
0
64
668
0.95
0.11
1.6
1.4
—
—
—
0
0
41
433
0.94
0.10
1.5
1.7
1.59
1.51
%
0.46
36
372
15
135
1.11
0.09
2.5
1.9
—
—
—
0
0
28
299
0.93
0.09
2.7
2.0
—
—
—
0
0
24
258
0.93
0.09
5.5
3.1
39.17
106.79
u/ml
0.78
24
249
29
306
0.95
0.07
1.2
1.2
60.77
122.69
u/ml
1.31
16
116
466
4655
1.00
0.00
6.3
5.5
1.92
1.99
mu/l
0.63
439
4228
0
9
0.00
0.00
0.0
1.1
—
15.26
—
0
9
6
61
0.98
0.00
3.3
2.1
1.19
1.20
mmol/l
—
6
61
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
0.40
—
0
5
6
62
0.97
-0.00
3.3
2.0
106.17
105.63
mmol/l
—
6
62
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
16
160
1.00
-0.00
2.4
2.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint AB1_OTHER_MYCOBAC and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| AB1_OTHER_MYCOBAC | 1.906 [1.65, 2.2] | < 0.001 |
| Birth year | 0.993 [0.98, 1.0] | 0.125 |
During the follow-up period (1.1.1998 — 31.12.2019), 658 out of 1676 females with AB1_OTHER_MYCOBAC died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| AB1_OTHER_MYCOBAC | 2.693 [2.15, 3.37] | < 0.001 |
| Birth year | 0.983 [0.97, 0.99] | < 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 619 out of 1250 males with AB1_OTHER_MYCOBAC died.
Mortality risk
Mortality risk for people of age
years, who have AB1_OTHER_MYCOBAC.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.197% | 0.472% |
| 5 | 1.066% | 2.948% |
| 10 | 2.455% | 6.89% |
| 15 | 4.73% | 12.749% |
| 20 | 8.37% | 21.26% |
Relationships between endpoints
↥Index endpoint: AB1_OTHER_MYCOBAC – Infection due to other mycobacteria
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data